missing translation for 'onlineSavingsMsg'
Läs mer

Tocris Bioscience™ Ruxolitinib
GREENER_CHOICE

Produktkod. 18715796
Change view
Klicka för att se tillgängliga alternativ
Kvantitet:
50 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Produktkod. Kvantitet
18715796 50 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Denna artikel kan inte returneras. Se returpolicy
Produktkod. 18715796 Leverantör Tocris Bioscience™ Leverantörsnummer 7064/50

Please to purchase this item. Need a web account? Register with us today!

Denna artikel kan inte returneras. Se returpolicy

Potent and selective JAK1/JAK2 inhibitor; orally bioavailable

Ruxolitinib is a potent and selective JAK1/2 inhibitor (IC50 values are 3.3 and 2.8 nM, respectively). Exhibits selectivity for JAK1/2 over Tyk2 and JAK3 (∼6-fold and >130-fold, respectively). Exhibits no significant inhibition against a commercial panel of 26 additional kinases. Inhibits JAK2V617F-mediated signaling and proliferation in Ba/F3 cells and HEL cells. Increases survival rates in a JAK2V617F-driven mouse model. Identified as targeting human host proteins that interact with SARS-CoV-2. Orally bioavailable.

Phosphate salt (Cat. No. 7048) also available.

TRUSTED_SUSTAINABILITY

Specifikationer

Kemiskt namn eller material (3 R)-3-Cyclopentyl-3-[4-(7 H-pyrrolo[2,3-d]pyrimidin-4-yl)-1 H-pyrazol-1-yl]propanenitrile
CAS 941678-49-5
Kvantitet 50 mg
Mål JAK Kinase Inhibitors
Molekylformel C17H18N6
Formel vikt 2323
Renhet 98%
Produkttitel
Välj ett problem

Genom att klicka på Skicka bekräftar du att du kan bli kontaktad av Fisher Scientific angående feedbacken du har lämnat i detta formulär. Vi kommer inte att dela din information för andra ändamål. All kontaktinformation som tillhandahålls ska också underhållas i enlighet med vår Sekretesspolicy.